文献速递结核与非结核分枝杆菌艾滋病与性传播感染

高负担地区痰液Ultra痕量阳性成人及青少年结核患病率与预测因素

Prevalence and Predictors of Tuberculosis in Adults and Adolescents With Sputum Trace Ultra Results in 2 High-Burden Clinical Settings.
PubMed 文献 · Clin Infect Dis · 2026-01-01

在乌干达和南非招募311例初始痰Xpert MTB/RIF Ultra痕量阳性成人及青少年,入组时痰培养确诊结核占20%(61/311,95%CI 15%-24%)。3个月内48%(145/301,95%CI 43%-54%)被判定需抗结核治疗;有结核症状、晚期HIV及无近期结核史与微生物学确诊结核相关,异常胸片或CRP升高亦相关。

要点

  • 痰Ultra痕量阳性者中约20%入组时培养确诊结核,3个月内约48%被建议治疗
  • 有结核症状、晚期HIV、无近期结核史者微生物学确诊结核风险更高
  • 无近期结核史者异常胸片或CRP升高亦与确诊结核相关

核心结论

  • 约半数痰Ultra痕量阳性者被建议抗结核治疗,该患病率支持在无法多模态检测和重复临床评估时治疗大多数此类患者。
  • 鉴于观察到的死亡率低,部分低风险特征且其他广泛可用诊断试验阴性者可安全推迟治疗并临床随访。

研究设计与样本

  • 在乌干达和南非招募初始结核诊断评估中痰Ultra痕量阳性的成人及青少年。
  • 入组时全面评估,结核状态不确定者不接受治疗随访,由结核临床医生定期再评估,最长3个月。
  • 评估结核患病率、相关患者特征及诊断结果。

主要发现

  • 311例痰Ultra痕量阳性者中,入组时痰培养确诊结核占20%(61/311,95%CI 15%-24%)。
  • 3个月内48%(145/301,95%CI 43%-54%)被判定需抗结核治疗。
  • 随访至微生物学结局者中,30%(68/227,95%CI 24%-36%)培养阳性,41%(99/240,95%CI 35%-47%)培养或Ultra阳性。
  • 2例死亡。
  • 有结核症状、晚期HIV、无近期结核史与微生物学确诊结核相关;无近期结核史者异常胸片或CRP升高亦相关。

临床怎么用

  • 痰Ultra痕量阳性且无法进行多模态检测和重复临床评估时,可考虑对大多数患者启动抗结核治疗。
  • 对低风险特征且其他广泛可用诊断试验阴性的患者,可在临床随访下安全推迟治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Some patients who test trace positive on Xpert MTB/RIF Ultra ("Ultra"), a highly sensitive molecular diagnostic platform, may not have tuberculosis (TB) disease. A better understanding of the prevalence of TB, associated clinical characteristics, and utility of additional diagnostic tests among people with trace sputum (PWTS) could aid clinical decision-making. METHODS: We enrolled adults and adolescents with trace-positive sputum on initial TB diagnostic evaluation in Uganda and South Africa. Participants were extensively evaluated at enrollment; those with uncertain TB status were followed off treatment, with interval reevaluations by TB clinicians, for up to 3 months. We assessed TB prevalence and associated patient characteristics and diagnostic results. RESULTS: Among 311 PWTS, TB was identified by sputum culture at enrollment in 20% of participants (61/311, 95% CI 15%-24%). Within 3 months, 48% (145/301, 95% CI 43%-54%) had been judged to warrant TB treatment, and among those followed until microbiologic outcomes, 30% (68/227, 95% CI 24%-36%) had positive culture and 41% (99/240, 95% CI 35%-47%) had positive culture or Ultra. Two participants died. Having TB symptoms, advanced human immunodeficiency virus (HIV), and no recent TB history were associated with microbiologically confirmed TB disease, as were an abnormal chest X-ray (in those without recent TB) or elevated C-reactive protein (CRP). CONCLUSIONS: Roughly half of PWTS were recommended TB therapy. This prevalence supports treating most PWTS when multimodal testing and repeated clinical evaluations are infeasible. However, given low observed mortality, some people with low-risk characteristics and negative results on other widely available diagnostic tests could safely defer treatment with clinical follow-up.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Visek C, Dalmat RR, Nalutaaya A, et al. Prevalence and Predictors of Tuberculosis in Adults and Adolescents With Sputum Trace Ultra Results in 2 High-Burden Clinical Settings. Clin Infect Dis. 2026. PMID: 41858248. doi:10.1093/cid/ciag019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。